If you're working on gaining access to the Sea 2 region in Sailor Piece, a big part of it is tracking down Ancient Fragment ...

The Creator Showdown 2026 will run from April 20 to April 24, 2026. Players can earn Creds by completing different quests.

Survive the Apocalypse is a survival experience on the Roblox platform where you can play as a solo or a team, spawn in a ...

Office Scripts in Excel offer a structured way to automate repetitive tasks, making it easier to manage large datasets or streamline workflows. Built into the “Automate” tab of Excel’s ribbon, this ...

GameSpot may get a commission from retail offers. When Barbarian and Weapons director Zach Cregger signed on to helm the next Resident Evil movie, it was described as "a revamp that will take the ...

Saudi Awwal Bank (SAB), one of the leading banks in the Kingdom of Saudi Arabia, is certified as a Leader in Innovation with a 7-Star rating, the highest level of global recognition for Certified ...

Express Scripts agreed to pay a $1.5 million administrative penalty and implement corrective actions following an investigation by the West Virginia Offices of the Insurance Commissioner. Between May ...

“Too many women’s scripts never even get a read,” co-founder Jan Kimbrough says. “We exist to change that." By Kimberly Nordyke Managing Editor, Digital The Women’s List, a nonprofit organization ...

The Federal Trade Commission has announced what it called a "landmark settlement" with Express Scripts over insulin pricing. The settlement resolves a lawsuit alleging that Express Scripts' conduct ...

The FTC first sued Express Scripts, CVS Caremark, and Optum in 2024, claiming anticompetitive and unfair rebating practices surrounding insulin. “Caremark, [Express Scripts], and Optum—as medication ...

The Federal Trade Commission has reached a landmark settlement with Express Scripts, one of the nation’s largest pharmacy benefit managers, requiring sweeping changes aimed at lowering insulin costs ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...